Androgen insensitivity syndrome classification: Difference between revisions

Jump to navigation Jump to search
 
(10 intermediate revisions by 2 users not shown)
Line 4: Line 4:


==Overview==
==Overview==
Androgen insensitivity syndrome (AIS) represents a spectrum of defects in androgen action and can be subdivided into three broad phenotypes such as CAIS. PAIS and MAIS.
Androgen insensitivity syndrome (AIS) represents a spectrum of defects in [[androgen]] action and can be subdivided into three broad [[phenotypes]] into complete androgen insensitivity syndrome (CAIS), mild androgen insensitivity syndrome (MAIS) and partial androgen insensitivity syndrome (PAIS).


==Classification==
==Classification==
Androgen insensitivity syndrome (AIS) represents a spectrum of defects in androgen action and can be subdivided into three broad phenotypes:<ref name="pmid20301602">{{cite journal |vauthors=Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Ledbetter N, Mefford HC, Smith RJH, Stephens K, Gottlieb B, Trifiro MA |title= |journal= |volume= |issue= |pages= |year= |pmid=20301602 |doi= |url=}}</ref>
*Based on the degree of genital masculinization, androgen insensitivity syndrome is divided into three categories:<ref name="pmid25395750">{{cite journal |vauthors=Bhaskararao G, Himabindu Y, Nayak SR, Sriharibabu M |title=Laparoscopic gonedectomy in a case of complete androgen insensitivity syndrome |journal=J Hum Reprod Sci |volume=7 |issue=3 |pages=221–3 |year=2014 |pmid=25395750 |pmc=4229800 |doi=10.4103/0974-1208.142498 |url=}}</ref><ref name="pmid19507547">{{cite journal |vauthors=Ohba K, Hayashida Y, Hakariya H, Ichinose S, Naitou S |title=[Case of complete androgen insensitivity syndrome] |language=Japanese |journal=Hinyokika Kiyo |volume=55 |issue=5 |pages=277–80 |year=2009 |pmid=19507547 |doi= |url=}}</ref><ref name="pmid19064222">{{cite journal |vauthors=Oakes MB, Eyvazzadeh AD, Quint E, Smith YR |title=Complete androgen insensitivity syndrome--a review |journal=J Pediatr Adolesc Gynecol |volume=21 |issue=6 |pages=305–10 |year=2008 |pmid=19064222 |doi=10.1016/j.jpag.2007.09.006 |url=}}</ref><ref name="pmid18760072">{{cite journal |vauthors=Hashmi A, Hanif F, Hanif SM, Abdullah FE, Shamim MS |title=Complete Androgen Insensitivity Syndrome |journal=J Coll Physicians Surg Pak |volume=18 |issue=7 |pages=442–4 |year=2008 |pmid=18760072 |doi=07.2008/JCPSP.442444 |url=}}</ref>


*Complete androgen insensitivity syndrome (CAIS), with typical female external genitalia
:*When the [[external genitalia]] is that of a normal [[female]] it is classified as complete androgen insensitivity syndrome (CAIS)
*Partial androgen insensitivity syndrome (PAIS) with predominantly female, predominantly male, or ambiguous external genitalia
:*When the [[external genitalia]] is that of a normal [[male]] it is classified as mild androgen insensitivity syndrome (MAIS)
*Mild androgen insensitivity syndrome (MAIS) with typical male external genitalia
:*When the [[external genitalia]] is partially, but not fully masculinized it is classified as partial androgen insensitivity syndrome (PAIS)


*Individuals with both partial androgen insensitivity syndrome (PAIS) and complete androgen insensitivity syndrome (CAIS) have 46 XY karyotypes. <ref name="pmid25395750">{{cite journal |vauthors=Bhaskararao G, Himabindu Y, Nayak SR, Sriharibabu M |title=Laparoscopic gonedectomy in a case of complete androgen insensitivity syndrome |journal=J Hum Reprod Sci |volume=7 |issue=3 |pages=221–3 |year=2014 |pmid=25395750 |pmc=4229800 |doi=10.4103/0974-1208.142498 |url=}}</ref>


{| style="border: 0px; font-size: 90%; margin: 3px;" align=center
'''Classification of Androgen Insensitivity Syndrome Phenotypes:'''' <ref name="pmid20301602">{{cite journal |vauthors=Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Ledbetter N, Mefford HC, Smith RJH, Stephens K, Gottlieb B, Trifiro MA |title= |journal= |volume= |issue= |pages= |year= |pmid=20301602 |doi= |url=}}</ref>
 
{| style="border: 0px; font-size: 90%; margin: 3px;" align="center"
| colspan="3" style="background: #4479BA; text-align: center;" | {{fontcolor|#FFF|'''Classification of Androgen Insensitivity Syndrome Phenotypes'''}}
| colspan="3" style="background: #4479BA; text-align: center;" | {{fontcolor|#FFF|'''Classification of Androgen Insensitivity Syndrome Phenotypes'''}}
|+  
|+  
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Type}}
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" | {{fontcolor|#FFFFFF|Type}}
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|External Genitalia}}
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" | {{fontcolor|#FFFFFF|External Genitalia}}
! style="background: #4479BA; padding: 5px 5px;" colspan=1 | {{fontcolor|#FFFFFF|Findings}}
! colspan="1" style="background: #4479BA; padding: 5px 5px;" | {{fontcolor|#FFFFFF|Findings}}
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" rowspan="2;" | CAIS - (Complete androgen insensitivity syndrome)
| rowspan="2;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" | CAIS - (Complete androgen insensitivity syndrome)
| style="padding: 5px 5px; background: #F5F5F5;" | Female (“testicular feminization”)
| style="padding: 5px 5px; background: #F5F5F5;" | Female (“testicular feminization”)
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
Line 36: Line 39:
*Distinct urethral and vaginal openings OR a urogenital sinus.
*Distinct urethral and vaginal openings OR a urogenital sinus.
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" rowspan="2;" | PAIS - (Partial androgen insensitivity syndrome)
| rowspan="2;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" | PAIS - (Partial androgen insensitivity syndrome)
| style="padding: 5px 5px; background: #F5F5F5;" | Ambiguous
| style="padding: 5px 5px; background: #F5F5F5;" | Ambiguous
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
Line 49: Line 52:
*Gynecomastia in puberty.
*Gynecomastia in puberty.
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" rowspan="1;" | MAIS - (Mild androgen insensitivity syndrome)
| rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" | MAIS - (Mild androgen insensitivity syndrome)
| style="padding: 5px 5px; background: #F5F5F5;" | Male (“undervirilized male syndrome”)
| style="padding: 5px 5px; background: #F5F5F5;" | Male (“undervirilized male syndrome”)
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |

Latest revision as of 14:27, 11 October 2017

Androgen insensitivity syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Androgen insensitivity syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Androgen insensitivity syndrome classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Androgen insensitivity syndrome classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Androgen insensitivity syndrome classification

CDC on Androgen insensitivity syndrome classification

Androgen insensitivity syndrome classification in the news

Blogs on Androgen insensitivity syndrome classification

Directions to Hospitals Treating Androgen insensitivity syndrome

Risk calculators and risk factors for Androgen insensitivity syndrome classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aravind Reddy Kothagadi M.B.B.S[2]

Overview

Androgen insensitivity syndrome (AIS) represents a spectrum of defects in androgen action and can be subdivided into three broad phenotypes into complete androgen insensitivity syndrome (CAIS), mild androgen insensitivity syndrome (MAIS) and partial androgen insensitivity syndrome (PAIS).

Classification

  • Based on the degree of genital masculinization, androgen insensitivity syndrome is divided into three categories:[1][2][3][4]
  • When the external genitalia is that of a normal female it is classified as complete androgen insensitivity syndrome (CAIS)
  • When the external genitalia is that of a normal male it is classified as mild androgen insensitivity syndrome (MAIS)
  • When the external genitalia is partially, but not fully masculinized it is classified as partial androgen insensitivity syndrome (PAIS)
  • Individuals with both partial androgen insensitivity syndrome (PAIS) and complete androgen insensitivity syndrome (CAIS) have 46 XY karyotypes. [1]

Classification of Androgen Insensitivity Syndrome Phenotypes:' [5]

Classification of Androgen Insensitivity Syndrome Phenotypes
Type External Genitalia Findings
CAIS - (Complete androgen insensitivity syndrome) Female (“testicular feminization”)
  • Absent OR rudimentary wolffian duct derivatives.
  • Absence or presence of epididymides and/or vas deferens.
  • Inguinal, labial, or abdominal testes.
  • Short blind-ending vagina.
  • Scant OR absent pubic AND/OR axillary hair.
Predominantly female (“incomplete AIS”)
  • Inguinal OR labial testes.
  • Clitoromegaly and labial fusion.
  • Distinct urethral and vaginal openings OR a urogenital sinus.
PAIS - (Partial androgen insensitivity syndrome) Ambiguous
  • Microphallus (<1 cm) with clitoris-like underdeveloped glans; labia majora-like bifid scrotum.
  • Descended OR undescended testes.
  • Perineoscrotal hypospadias OR urogenital sinus.
  • Gynecomastia (development of breasts) in puberty.
Predominantly male
  • Simple (glandular or penile) OR severe (perineal) “isolated” hypospadias with a normal-sized penis and descended testes OR severe hypospadias with micropenis, bifid scrotum, and either descended OR undescended testes.
  • Gynecomastia in puberty.
MAIS - (Mild androgen insensitivity syndrome) Male (“undervirilized male syndrome”)
  • Impaired spermatogenesis AND/OR impaired pubertal virilization.
  • Gynecomastia in puberty.

References

  1. 1.0 1.1 Bhaskararao G, Himabindu Y, Nayak SR, Sriharibabu M (2014). "Laparoscopic gonedectomy in a case of complete androgen insensitivity syndrome". J Hum Reprod Sci. 7 (3): 221–3. doi:10.4103/0974-1208.142498. PMC 4229800. PMID 25395750.
  2. Ohba K, Hayashida Y, Hakariya H, Ichinose S, Naitou S (2009). "[Case of complete androgen insensitivity syndrome]". Hinyokika Kiyo (in Japanese). 55 (5): 277–80. PMID 19507547.
  3. Oakes MB, Eyvazzadeh AD, Quint E, Smith YR (2008). "Complete androgen insensitivity syndrome--a review". J Pediatr Adolesc Gynecol. 21 (6): 305–10. doi:10.1016/j.jpag.2007.09.006. PMID 19064222.
  4. Hashmi A, Hanif F, Hanif SM, Abdullah FE, Shamim MS (2008). "Complete Androgen Insensitivity Syndrome". J Coll Physicians Surg Pak. 18 (7): 442–4. doi:07.2008/JCPSP.442444 Check |doi= value (help). PMID 18760072.
  5. Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean L, Bird TD, Ledbetter N, Mefford HC, Smith R, Stephens K, Gottlieb B, Trifiro MA. PMID 20301602. Vancouver style error: initials (help); Missing or empty |title= (help)

Template:WH Template:WS